PGL 0.00% 44.5¢ prospa group limited.

+ + data and comments + +, page-16

  1. 2,086 Posts.
    re: + + phase ii, nsclc trial + + Thanks Mitch. Interesting reading. Progen has a lot of plus's going for it at present. The success to date of the Avastin Trials is a major upside factor.
 
watchlist Created with Sketch. Add PGL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.